PEAK6 Investments’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-4,941
Closed -$222K 4971
2022
Q4
$222K Sell
4,941
-14,831
-75% -$671K ﹤0.01% 3213
2022
Q3
$946K Buy
+19,772
New +$1.08M ﹤0.01% 2264
2022
Q1
Sell
-1,069
Closed -$161K 5941
2021
Q4
$161K Sell
1,069
-1,403
-57% -$189K ﹤0.01% 4130
2021
Q3
$295K Buy
+2,472
New +$272K ﹤0.01% 3679
2020
Q2
Sell
-1,644
Closed -$131K 4828
2020
Q1
$106K Buy
1,644
+143
+10% +$10K ﹤0.01% 3269
2019
Q4
$89K Buy
+1,501
New +$92.6K ﹤0.01% 2903

Other funds holding TNDM

PEAK6 Investments's TNDM Position: Q1 2023 in Review

PEAK6 Investments sold out of Tandem Diabetes Care (TNDM) in Q1 2023, closing a stake of 4,941 shares — an estimated $222K sold.

PEAK6 Investments first reported a position in TNDM in Q4 2019 and held it in 6 quarters. The position peaked at $946K in Q3 2022. 273 funds tracked by Wall St. Rank hold TNDM as of Q1 2023.

  • PEAK6 Investments reported no remaining Tandem Diabetes Care position as of Q1 2023 after selling out during the quarter.
  • PEAK6 Investments sold 4,941 Tandem Diabetes Care shares in Q1 2023, an estimated $222K.
  • PEAK6 Investments first reported a position in Tandem Diabetes Care in Q4 2019 and held it in 6 quarters.
  • PEAK6 Investments's Tandem Diabetes Care position peaked at $946K in Q3 2022.
  • 273 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2023.

Based on PEAK6 Investments's 13F filing for Q1 2023, filed 12 May 2023.